This inventor holds 1 USPTO granted patent. Top assignee: Blueprint Medicines Corporation. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Gilles Caillot - Innovator in Synthetic Methods for Treating Diseases
Introduction
Gilles Caillot is an inventor based in Saint Leu d'Esserent, France. He is known for his work in developing synthetic methods and intermediates for producing compounds that are useful in treating diseases related to mutant KIT and PDGFRA. His innovative approach aims to address significant medical challenges.
Latest Patent Applications
Gilles Caillot has submitted a patent application titled "SYNTHETIC METHODS AND INTERMEDIATES FOR PRODUCING COMPOUNDS FOR TREATING KIT- AND PDGFRA-MEDIATED DISEASES." This application provides methods and intermediates for making Compound A or a pharmaceutical salt thereof, which are essential for treating diseases and conditions associated with mutant KIT and PDGFRA.
Conclusion
Gilles Caillot's contributions to synthetic methods in the pharmaceutical field highlight his commitment to addressing critical health issues. His ongoing work in this area may lead to significant advancements in treatment options for patients.